Oscar Health (OSCR) reported Q1 earnings Wednesday of $0.92 per diluted share, up from $0.62 a year earlier.
Analysts polled by FactSet expected $0.79.
Total revenue for the quarter ended March 31 was $3.05 billion compared with $2.14 billion a year earlier.
Analysts surveyed by FactSet expected $2.84 billion.
The company reaffirmed its 2025 revenue guidance of $11.20 billion to 11.30 billion. Analysts polled by FactSet expect $11.15 billion.
Shares of the company were up nearly 16% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。